{
  "id": 5359187,
  "title": "Akeso, Summit cancer drug confirms lung cancer survival benefit",
  "url": "https://urgent.news/2026/09/03/akeso-summit-cancer-drug-confirms-lung-cancer-survival-benefit",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-09-03T13:14:12.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/akeso-summit-cancer-drug-ivonescimab-confirms-lung-cancer-survival-benefit/829538/"
  },
  "original_language": "en",
  "account": null,
  "summary": "A new data cut of a trial pitting ivonescimab, a bispecific antibody, against Merck’s Keytruda showed the new drug helped people live longer.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Vietnam Investment Review",
        "title": "Akeso cancer trial meets overall survival endpoint against Pembrolizumab",
        "url": "https://urgent.news/2026/09/03/akeso-cancer-trial-meets-overall-survival-endpoint-against",
        "published": "2026-09-03T07:50:18.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}